Drug Type Antibody fusion proteins |
Synonyms IGN-004, IGN004 |
Target |
Action modulators, agonists |
Mechanism IFNA modulators(interferon alpha modulators), IFNAR agonists(Interferon alpha/beta receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 04 Nov 2015 | |
Hematologic Neoplasms | Discovery | United States | - | |
Hematologic Neoplasms | Discovery | United States | - | |
Multiple Myeloma | Discovery | United States | - | |
Solid tumor | Discovery | United States | - | |
Solid tumor | Discovery | United States | - |